Natera Inc (NTRA)
Natera - 20 Abstracts at AACR Highlight Scale, Innovation and Clinical Impact of Natera’s Oncology Platform
Natera - 20 Abstracts at AACR Highlight Scale, Innovation and Clinical Impact of Natera’s Oncology Platform
Greenwich LifeSciences Provides Update on Patent Claims Potentially Doubling GP2 Market Potential
Serina Therapeutics to Present at the 5th LNP Formulation & Process Development Summit
Ouster Announces Date for First Quarter 2026 Earnings Call
KRISPY KREME® Celebrates Malcolm in the Middle Return with Exclusive Specialty Pack
Linde Announces First Quarter 2026 Earnings and Conference Call Schedule
Sun Pacific Unlocks New Insights Through NIQ Collaboration
Greenwich LifeSciences Provides Update on Patent Claims Potentially Doubling GP2 Market Potential
20 Abstracts at AACR Highlight Scale, Innovation and Clinical Impact of Natera’s Oncology Platform
Emera Teleconference on May 8 to Discuss Q1 2026 Results